Abstract:Although many researchers of Parkinson's disease (PD) have shifted their focus from the central nervous system (CNS) to the peripheral blood, a significant knowledge gap remains between PD severity and the peripheral immune response. In the current study, we aimed to map the peripheral immunity atlas in peripheral blood mononuclear cells (PBMCs) from PD patients and healthy controls using single-cell RNA sequencing (scRNA-seq). Our study employed scRNA-seq analysis to map the peripheral immunity atlas in PD by profiling PBMCs from PD-Early, PD-Late patients and matched controls. By enlarging the blood sample size, we validated the roles of NK cells in numerous immune-related biological processes. We also detected the infiltration of NK cells into the cerebral motor cortex as the disease progressed, using human brain sections, and elucidated the communication between the periphery and CNS and its implications for PD. As a result, cell subpopulation atlases in PBMCs from PD patients and healthy controls along with differentially expressed genes in NK cells were identified by scRNA-seq analysis, representing 6 major immune cell subsets among which NK cells declined in the progression of PD. We further validated NK cell reduction in increasing samples and found that they participated in numerous immune-related biological processes and infiltration into the cerebral motor cortex as the disease proceeded, evidencingd the close communication between the peripheral immune response and CNS. Strikingly, XCL2 positively correlated with PD severity, with good predictive performance of PD and specific expression in subclusters C2 and C5 of NK cells. All these findings delineated the critical role of peripheral immune response mediated by NK cells in the pathogenesis of PD. NK cell-specific XCL2 could be used as a diagnostic marker for treating PD. The indispensable function of NK cells and NK cell-specific molecular biomarkers highlighted the implication of the peripheral immune response in PD progression. Trial registration: ChiCTR, ChiCTR1900023975. Registered 20 June 2019 - Retrospectively registered, https://www.chictr.org.cn/showproj.html?proj=31035 .

Alterations of Peripheral Lymphocyte Subsets in Isolated Rapid Eye Movement Sleep Behavior Disorder

Different Perivascular Space Burdens in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease.

Different Patterns of Exosomal Α‐synuclein Between Parkinson's Disease and Probable Rapid Eye Movement Sleep Behavior Disorder

Alterations of Brain Structural Network in Parkinson’s Disease with and Without Rapid Eye Movement Sleep Behavior Disorder

Wider and Faster Degeneration of White Matter in Parkinson’s Disease with Possible REM Sleep Behaviour Disorder

Peripheral blood inflammatory cytokines are associated with rapid eye movement sleep behavior disorder in Parkinson’s disease

Impaired Ocular Tracking and Cortical Atrophy in Idiopathic Rapid Eye Movement Sleep Behavior Disorder

Retinal Nerve Fiber Layer Thinning: a Window into Rapid Eye Movement Sleep Behavior Disorders in Parkinson’s Disease

Increased muscle sympathetic nerve activity and impaired baroreflex control in isolated REM-sleep behavior disorder

Microstructural Alterations of the Hypothalamus in Parkinson's Disease and Probable REM Sleep Behavior Disorder

Single-cell RNA sequencing reveals peripheral immunological features in Parkinson's Disease

Plasma immune markers in an idiopathic REM sleep behavior disorder cohort

Longitudinal Network Changes and Phenoconversion Risk in Isolated REM Sleep Behavior Disorder

Early- and late-onset of isolated rapid eye movement sleep behavior disorder: A retrospective cohort study

Abnormal Subpopulations of Peripheral Blood Lymphocytes Are Involved in Parkinson's Disease

Possible predictors of phenoconversion in isolated REM sleep behaviour disorder: a systematic review and meta-analysis

Clinical features of Parkinson's disease with and without rapid eye movement sleep behavior disorder

Peripheral immune cell response to stimulation stratifies Parkinson's disease progression from prodromal to clinical stages

Neuroimaging evidence of glymphatic system dysfunction in possible REM sleep behavior disorder and Parkinson’s disease

Considering REM Sleep Behavior Disorder in the Management of Parkinson’s Disease

Altered connectivity in the cognitive control-related prefrontal cortex in Parkinson's disease with rapid eye movement sleep behavior disorder